Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA expects smoother registration process

This article was originally published in The Gray Sheet

Executive Summary

After sending out 15,000 letters to device manufacturers thought to be non-compliant with facility registration required under the FDA Amendments Act, CDRH has converted approximately 13,700 to "inactive" status, the agency says. Ruling out a large number of those facilities has freed up the device center to communicate with firms that should be registering and focus on ensuring compliance as the FY 2009 registration fee period approaches. FDAAA, signed into law last fall, requires every device firm regulated by FDA to register electronically (unless given a waiver to use paper) and to pay an annual registration fee by Dec. 31 (1"The Gray Sheet" Oct. 1, 2007, p. 6)

You may also be interested in...



FDA Bill Signed Into Law; CDRH Set To Implement Fee-Based e-Registration

President Bush Sept. 27 signed into law the FDA Amendments Act, setting in motion significant reforms in the way the agency will oversee the safety of health care products

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Falling Sales Force New Priorities At Roche

The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel